Abstract It has been proven that the pharmacist plays an important role in the critical care multidisciplinary team (MDT). The pharmacist continuously reviews and optimises medications according to changes in the patient's clinical status and identifies drug interactions or adverse drug events. Due to the significant costs of critical care medications, the pharmacist must also provide costeffective treatments.
This interactive workshop will teach participants how to develop a therapeutic plan and monitor response in critical care patients, improve patient safety and evaluate cost effectiveness. Participants will apply evidence-based practice across a variety of critical care scenarios and present their best-practice recommendations to a simulated critical care MDT.
The workshop is directed at existing critical care pharmacists and those who are considering the critical care specialisation as part of their future hospital career.
Learning objectives After the workshop, participants should be able to: • illustrate the essential role of the pharmacist in the critical care MDT • distinguish the principal activities of the critical care pharmacist in terms of: - optimisation of pharmacotherapy - reduction of medication errors - prevention of adverse drug events - reduction of costs • examine how these principle activities enhance patient safety in a critical care unit. • analyse a critical care scenario, identify issues with existing and proposed treatments, and recommend evidence-based practice to the MDT
Educational need addressed This workshop shares best practice for critical care pharmacists for: prevention of medication errors and adverse drug events; optimisation of pharmacotherapy; and cost effectiveness.
Keywords: critical care, medicine optimization, evidence-based practice, multidisciplinary team.